bromodeoxyuridine has been researched along with Central Nervous System Neoplasm in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kogure, S; Murayama, H; Sadakane, K; Yamanoha, B | 1 |
| Cabanillas, F; Cox, JD; Dabaja, BS; Ha, CS; Kyritsis, AP; Levin, V; McLaughlin, P; Meyers, CA; Preti, HA; Pro, B; Seabrooke, LF; Wilder, RB; Yung, WK | 1 |
| Fung, KM; Lee, VM; Trojanowski, JQ | 1 |
| Dinda, AK; Karak, AK; Kharbanda, K; Mathur, M; Roy, S; Sarkar, C | 1 |
| Feldkamp, MM; Guha, A; Lau, N | 1 |
1 trial(s) available for bromodeoxyuridine and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Bromodeoxyuridine; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Infusions, Intravenous; Lymphoma; Male; Methotrexate; Middle Aged; Treatment Outcome | 2003 |
4 other study(ies) available for bromodeoxyuridine and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Low-power 808-nm laser irradiation inhibits cell proliferation of a human-derived glioblastoma cell line in vitro.
Topics: Bromodeoxyuridine; Cell Count; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; DNA; Fluoresceins; Fluorescent Dyes; Glioblastoma; Humans; Low-Level Light Therapy | 2012 |
Dynamics of cell proliferation and cell death during the emergence of primitive neuroectodermal tumors of the immature central nervous system in transgenic mice.
Topics: Animals; Blotting, Southern; Bromodeoxyuridine; Cell Death; Cell Division; Cell Transformation, Neoplastic; Central Nervous System; Central Nervous System Neoplasms; Epithelial Cells; Immunoenzyme Techniques; Immunohistochemistry; Mice; Mice, Transgenic; Microscopy, Immunoelectron; Neuroectodermal Tumors, Primitive | 1995 |
Cell culture studies on human nerve sheath tumors.
Topics: Adolescent; Adult; Bromodeoxyuridine; Cell Division; Central Nervous System Neoplasms; Child; DNA, Neoplasm; Female; Humans; Immunoenzyme Techniques; Male; Microscopy, Electron; Middle Aged; Nerve Sheath Neoplasms; Neurilemmoma; Neurofibroma; Phagocytosis; S100 Proteins; Tumor Cells, Cultured | 1994 |
Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Astrocytoma; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Bromodeoxyuridine; Cell Cycle; Cell Division; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Endothelial Growth Factors; Enzyme Inhibitors; ErbB Receptors; Farnesyltranstransferase; Genes, ras; Growth Inhibitors; Humans; Lymphokines; Membrane Proteins; Methionine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myelin Basic Protein; Neovascularization, Pathologic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |